Two Sigma Securities’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Two Sigma Securities’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,635	Closed	-$28K	–	3312
2022 Q2	$28K	Buy	+12,635	New	+$25.2K	﹤0.01%	1921

Two Sigma Securities's ETTX Position: Q3 2022 in Review

Two Sigma Securities sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 12,635 shares — an estimated $28K sold.

Two Sigma Securities first reported a position in ETTX in Q2 2022 and held it in 1 quarter. The position peaked at $28K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Two Sigma Securities reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Two Sigma Securities sold 12,635 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $28K.
Two Sigma Securities first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2022 and held it in 1 quarter.
Two Sigma Securities's Entasis Therapeutics Holdings Inc. position peaked at $28K in Q2 2022.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.